Finally, recent studies suggested HFABP was associated with specific features of brain atrophy and white matter Hyperintensities burden, independently of amyloid and tau pathology biomarkers (Clark et al., 2022; Vidal-Piñeiro et al., 2022). The gene discussed is MAPT; the disease is Brain atrophy.